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1 Introduction
Disclosure of ingredients and inclusion of a standardized label has been required on all US food
and beverage since 1994 as a result of the National Labeling Education Act (NLEA, [1]). The
United States Food and Drug Administration [2] initially estimated, among other benefits,
roughly 725,000 avoided cases of cancer and chronic heart disease over a 20-year period and a
health care savings between $4.4 and $26.5 billion through expected dietary changes resulting
from the NLEA.
Twenty years later, however, the effect of the NLEA on health outcomes remains largely
unknown, as literature exploring the effect of label use has yielded mixed conclusions. While
Variyam and Cawley [3] and Loureiro et al. [4] found a significant reduction in body mass index
(BMI) among women label users, Drichoutis et al. [5] found evidence that increased label use
actually caused higher BMI’s. However, both Variyam and Cawley and Loureiro et al.
dichotomized label use, initially measured on a 5-pt scale, into ‘sometimes’ frequency or above,
making inference at a specific label use level impossible. Further, in dichotomizing an ordered
exposure, both studies were more likely to suffer from bias due to confounded assignment
mechanism [6].
Estimating the effects of an exposure on an ordinal scale is useful for many public health
interventions. For example, extensive clinical trials have contrasted the duration, length, and
intensity levels of physical activity (including [7, 8], to name a few). Such research has aided in
proposing recommendations for physical activity, including those touted by the U.S. Surgeon
General [9]. Obviously, these guidelines cannot be enforced, however they were written in order
to motivate people to live healthier lifestyles, and to identify the average effects that are
expected due to different activity levels.
Similar guidelines on how often one should read nutritional labels have not been issued, despite
label use being a priority for several United States organizations. The U.S. Food and Drug
Administration [10], the American Heart Association [11], and the American Diabetes
Association [12], for example, all include label use directions on their websites. The Mayo Clinic
[13] goes as far as urging patients to ‘practice’ label use when food shopping. However, none of
these organizations supply any specific guidelines of how often individuals should be reading
nutritional labels.
Observational data that use a simple comparison of health outcomes across those at different
label use levels has limitations, because subjects in these label use groups differ with regard to
personal, socio-economic and demographic characteristics. For example, readers of nutrition
labels are, on average, more active and health-conscious [14, 15]. With two treatment groups, a
common statistical tool used to adjust for differences in the covariates’ distribution in
estimation of the treatment effect is the propensity score, defined by Rosenbaum and Rubin [16]
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as the probability of receiving treatment conditional on a set of observed covariates. Most
propensity score methods and applications deal with binary treatments, while exposure to label
use is often measured using an ordinal scale. In the 2005-06 National Health and Nutrition
Examination Survey (NHANES) data, label use is measured on a five-point scale, never, rarely,
sometimes, most of the time (often), or always. Drichoutis et al. [5] employed binary
propensity score methods across the ten possible pairs of label levels in their analysis of the
NHANES, which yielded pairwise causal effect estimates that were not transitive. Specifically,
estimates suggest that while sometimes label use level yields lower BMI than rare level and
that rare level causes lower BMI than never level, sometimes level frequency actually results in
a significantly higher BMI (p-value <0.05) than never level.
We extend the data set used by Drichoutis et al. [5] and reanalyze it with a generalized
propensity score method that will result in transitive estimates of the causal effects of increased
label use on BMI between all pairs of label use levels. In doing so, this manuscript provides
three important extensions to approaches which have been previously designed for ordinal
exposures [17, 18]. Following the separation of the design and analysis paradigm in
observational studies proposed by [19], we propose and implement novel graphical methods as
well as introduce new metrics for assessing and depicting covariates’ similarity between
individuals at different exposure levels. Second, we couple the subclassification based strategies
of [18] and [20] with regression adjustments to estimate causal effects and to obtain more precise
and accurate point estimates. Lastly, we use simulations to demonstrate the benefits of
combining subclassification with regression adjustment, relative to either method alone and to
other previously proposed methods for ordinal exposures. Although previous statistical
literature has touched on some of the analysis phase methods, the combination of the design,
simulation, and analysis phases presented here provide other investigators a complete case study
for estimating causal effects from observational studies with ordinal treatments. Our method is
implemented on the 2005-06 NHANES, and causal effect estimates suggest that reduction in
BMI only occurs when reading labels often or always.
The outline of this paper is as follows. Section 2 introduces our notation, and Section 3 details
our use of subclassification with regression adjustment to estimate the set of causal effects across
levels of an ordinal exposure. Section 4 implements the proposed method on the NHANES data,
Section 5 summarizes our results, and Section 6 details a simulation study. Section 7 concludes.
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2 Causal Inference & the Rubin Causal Model
2.1 Notation for binary treatment
Neyman [21] first described treatment effects in the context of potential outcomes for a
randomized experiment. This concept was expanded to observational studies in what was
eventually termed the ‘Rubin Causal Model’ (RCM) [22, 23].
Let Yi, X i, and Ti be the observed outcome, set of p covariate values, and binary treatment
indicator, respectively, for each subject i = 1,... n, n<N , where n is the sample size and N is
the population size which is possibly infinite, with treatment Ti ∈ T , T = {0, 1}.
A commonly made assumption in the RCM is the stable unit treatment value assumption
(SUTVA) [24]. SUTVA specifies both that the set of potential outcomes for a subject depends
only on the treatment that subject was assigned to, and not on the treatment assignment of
others, and that within each treatment condition, there are not multiple versions of the
treatment. Assuming SUTVA, the potential outcome for unit i can be written as
Yi(Ti = t) = Yi(t), which represents subject i’s outcome if he or she would have received
treatment t.
One common estimand of interest is the population average treatment effect (PATE), which is
often approximated by using the sample average treatment effect (SATE).
PATE = E[Y (1)− Y (0)] (1)
SATE =
1
n
n∑
i=1
(Yi(1)− Yi(0)) (2)
In practice, however, each individual receives either the treatment or the control at the same
point in time, but not both, and only Yi(1) or Yi(0) is observed for each unit, also known as the
fundamental problem of causal inference [22]. As a result, the RCM commonly relies on the
assumption S1 to estimate 1 and 2.
S1: Strongly ignorable treatment assignment: (i) Pr({Y (0), Y (1)} |T,X) =
Pr({Y (0), Y (1)} |X) and (ii) 0<Pr(T = t|X) for t ∈ {0, 1} [16]. Under strongly ignorable
treatment assignment, the set of potential outcomes and treatment assignment are
conditionally independent given X. Implicit in this assumption is that differences in
outcomes between those with the same X are unbiased estimates of the treatment’s causal
effect to units with that X.
To estimate causal effects from observational data, matching subjects with the same X who
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received different treatments is an effective way of reducing bias, but as the dimension of X
increases, this is nearly impossible [25]. Propensity scores enable inference under the RCM even
in a high dimensional setting. Let e(X) = Pr(T = 1|X) be the propensity score. If treatment
assignment is strongly ignorable given X, then it is also strongly ignorable given e(X),
Pr({Y (0), Y (1)} |T, e(X)) = Pr({Y (0), Y (1)} |e(X)). Thus, the comparison of units with equal
e(X)’s is unbiased for estimating unit level effects, and averaging over the distribution of e(X)
in the population results in an unbiased estimate of the PATE [16].
2.2 Expansions for more than two exposure levels
Assuming SUTVA, for Z exposures or exposure levels, with T = {1...Z}, let
Yi = {Yi(1), Yi(2), ..., Yi(Z)}, where Yi is the set of potential outcomes for unit i. With an
ordinal exposure, possible estimands of interest are the population average treatment effects
between exposure levels t and s, PATEt,s, for all pairs {t, s}, where t, s ∈ T , which are
commonly approximated by the sample average treatment effects, SATEt,s.
PATEt,s = E[Y (t)− Y (s)] (3)
SATEt,s =
1
n
n∑
i=1
(Yi(t)− Yi(s)) (4)
As with binary treatment, we cannot observe each SATEt,s because each unit only receives one
treatment, and therefore SATEt,s is a random quantity due to the assignment mechanism being
random. Assuming that the sample is randomly chosen from the population, then SATEt,s is an
approximation for the PATEt,s. Because most applications are usually trying to estimate effects
generalizing to the population, from this point forward we will define PATEt,s as our estimand
of interest, and assume that the observed data was sampled at random from the population.
To estimate the PATE across exposure pairs, S1 is expanded such that a strongly ignorable
treatment assignment mechanism (also called strong unconfoundedness) for multiple exposures
states that (i) Pr[Y|T = t,X] = Pr[Y|X] and (ii) 0<Pr[T = t|X] ∀ t ∈ T . As in the binary
treatment setting, SUTVA and a strongly ignorable treatment assignment mechanism enable us
to estimate E[Y (t)], for all t, by conditioning on the observed covariates.
The propensity score has been expanded to multiple exposures through the generalized
propensity score (GPS), r(t,X) = Pr(T = t|X = x) [18, 26, 27]. While propensity scores for
binary treatment enable us to condition on a scalar in order to estimate treatment effects, the
GPS with a discrete exposure may consist of multiple dimensions, thus requiring to condition on
an entire vector of treatment assignment probabilities, r(X) = (r(1,X), ..., r(Z,X)). As a
result, two individuals with the same r(t,X) for one specific treatment level may not be
equivalent with regards to their entire r(X). Thus, differences in outcomes between subjects
with different exposure levels and similar r(t,X), but differing r(X), are not generally unbiased
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causal effect estimates [26].
Joffe and Rosenbaum [17] and Imai and van Dyk [18] noted that modeling an ordinal exposure
using an ordered logit model, also referred to as the proportional odds model [28], can provide a
shortcut to conditioning on a multidimensional r(X). The ordered logit model is appropriate
for exposures measured in doses (e.g., low, medium, high). For example, with Z total
treatments (exposure levels), assuming
log
(
P (Ti<t)
P (Ti ≥ t)
)
= θt − β
TXi, t = 1, ..., Z − 1 (5)
and defining the balancing score, b(X), as a function of the covariates such that Pr(T = t|b(X))
= Pr(T = t|b(X),X), the proportional odds model provides a scalar b(X). Specifically, for
βT = (β1, ..βp)
T , βTX is a balancing score, such that
Pr(T = t|βTX) = Pr(T = t|X,βTX) for t = 1, ....Z (6)
The combination of Result (6) with the assumption of a strongly ignorable treatment
assignment mechanism allows us to establish that Y and the treatment assignment are
conditionally independent given βTX (for a proof, see Imai and van Dyk [18]),
Pr[Y|T = t,βTX] = Pr[Y|βTX] (7)
Under the expanded versions of SUTVA and S1, differences in observed Y ’s between subjects
with different exposure levels but equal βTX are unbiased estimates of causal effects at that
βTX . To estimate the PATEt,s for all treatment pairs {t, s}, we want to average
E[Y (t)− Y (s)|βTX] over the distribution of βTX. Formally, we would estimate E[Y (t)− Y (s)]
using the following:
E[Y (t)− Y (s)] = E[E(Y (t)− Y (s)|X)]
= E[E(Y (t)− Y (s)|X ,βTX)]
= E[E(Y (t)− Y (s)|βTX)] (by Result (6))
=
∫
(E[Y (t)|T = t,βTX ]− E[Y (s)|T = s,βTX ])Pr[βTX ]d(βTX) (8)
Direct computation of (8), however, is difficult because it requires integrating over the
probability distribution of βTX.
One approach for approximating the PATEt,s is to partition subjects with similar values of
βTX into subclasses, estimating the effect within each subclass, and combining these effects
using a weighted average. A second alternative could be the use of radius matching [29] to pair
subjects with roughly equivalent βTX ’s, and average across pairs. However, individual
matching techniques are not as well suited for multiple treatments [26]. A third approach, which
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is discussed in Section 3.3, uses inverse probability weighting.
3 Subclass weighted causal effects for an ordinal exposure
3.1 Design phase
Estimation of causal effects using observational data is composed of two phases: the design
phase and the analysis phase [30]. The design phase is done without the outcome in sight, and
with the intent of obtaining the same treatment effects which would have been obtained in a
completely randomized design [19]. As suggested by Joffe and Rosenbaum [17] and implemented
by Lu et al. [31], we first use Equation (5) to fit Pr(T |X) and generate an estimated βˆXi for
each individual, where βˆ is the maximum likelihood estimate of β. The goal in the design phase
is to group subjects which are similar with respect to the observed covariates [19]. Thus, we are
not concerned with assessing the fit of treatment assignment (e.g., testing the proportional odds
assumption), but whether balance on all covariates is obtained across treatment groups.
3.1.1 Covariate choice
The choice of which covariates to include in the generalized propensity score model should be
made with the intent of satisfying the assumption of strong ignorability. Primarily, previous
scientific research should be used to instruct choice of X [30], with all measured pre-treatment
variables associated with both the treatment assignment and the outcome included [32]. In
addition, when in doubt, Stuart [25] recommends a ‘liberal’ inclusion variables associated with
either the treatment assignment or the outcome, because exclusion of variables which are
associated with the treatment assignment mechanism can increase bias.
While it cannot be verified that the chosen X satisfies the assumption of strong ignorability,
Stuart [25] argues that strong ignorability is often more valid than it appears because
controlling for observed covariates also controls for correlated but unobserved ones. As part of
the covariate selection, we propose to examine if any covariates which were not included in the
treatment assignment model are also balanced across subclasses. Exact implementation will be
described in Section 5.
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3.1.2 Common support
As with propensity score analysis for binary treatment, it is important to eliminate subjects
outside the range of common support [33]. With binary treatment, a common support is often
considered to be the range of propensity scores of those receiving both treatments. For an
ordinal exposure, an extension is to use a common support region of the linear predictor, which
eliminates subjects with βˆTX beyond the range of βˆTX values among those on other
treatments. It is recommended that the propensity score model be re-fit after subjects are
dropped to ensure that the estimated propensity scores are not disproportionately impacted by
those outside the common support [34]. Dropping units also changes the estimand of interest to
include only units with a large enough probability of receiving any of the treatments. This is a
different estimand than the PATEt,s, which cannot be estimated without making unassailable
assumptions. Thus, it is good practice to describe the population which the estimand is
generalizable to, using the observed covariates.
The remaining subjects that are not discarded are partitioned into K subclasses, where each
subclass contains subjects with similar βˆTX. This partitioning is aimed at generating similar
covariates’ distributions for all treatment levels in each subclass. The choice of K is flexible, and
it has been suggested to examine the covariate balance for multiple values of K [30]. Higher K
will yield better within-subclass homogeneity of the covariates, resulting in smaller
within-subclass bias. Too large of a K will result in low numbers of subjects within each
subclass, which could restrict our ability to estimate causal effects when there are no units at a
specific treatment level to compare to. For simplicity, we partition units into subclasses such
that an equal number of units are within each subclass. Cochran and Rubin [35] found little
improvement when comparing the bias reduction of optimal subclassification to equally spaced
subclassification with a single covariate and a binary treatment, and Rosenbaum and Rubin [36]
provided similar recommendations when estimating the treatment effect with multiple covariates
and binary treatment. Our recommendation is to use equally spaced subclasses with ordinal
treatments and multiple covariates, but this is an area of further research.
Let nk be the number of subjects in subclass k, k = 1, ...,K. With binary treatment and p
covariates in the propensity score model, it has been recommended to keep (i) at least three
subjects at each combination of the subclass and treatment and (ii) nk>p+ 2 [34]. Our related
recommendation is to generate the largest K possible with both (i) at least 3 + Z subjects at
each exposure level in each subclass and (ii) nk>p+ Z.
3.1.3 Balance checks
To ensure that subclassification reduced the covariates’ bias across the different treatment
groups, it is important to check the within-subclass distributions of each covariate before
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looking at within-subclass outcomes [30, 19]. This process examines how closely each subclass
mimics a randomized experiment in which the distributions of covariates at each exposure level
are similar in expectation.
The following two-step procedure was used to examine the covariate distributions within each
subclass. First, tabular and graphical approaches assess the distributions of both βˆTX and the
continuous covariates in X by exposure level within each subclass [37]. These checks include
side-by-side boxplots of the balancing scores and continuous variables at each exposure level in
each subclass.
Second, the dependencies between exposure level and covariate within each subclass, for all
covariates, will be compared to both the dependencies in the original data and the hypothetical
distribution of the statistics which would have occurred in a randomized experiment. Here, we
use Kendall’s τb, abbreviated as τ from this point forward, which is a rank correlation
coefficient, where positive τ values indicate that higher ranks of one covariate are positively
associated with higher ranks of the exposure. Under the null distribution that the covariate and
exposure are independent, τ = 0, and sample τ statistics are approximately distributed as
standard Normal, making τ useful for examining non-linear correlations. We plot histograms of
sample τ test statistics for each covariate at each subclass to check for normality, as well as to
identify the proportion of τ statistics which remain significant after subclassification, relative to
nominal level α.
Examining all of the τ values for each covariate in each subclass may be extensive with a large
number of covariates. One way to summarize the benefits of subclassification is to average the
within-subclass τ estimates for each variable over the number of subclasses, and compare these
results to the values found in the original data. Formally, let τpk be the estimated τ between
exposure level and covariate p in subclass k, and let wk =
nk
n
be the proportion of subjects in
subclass k. We define τ p, the weighted subclass-averaged τ , as
τp =
K∑
k=1
τpkwk
Contrasting the τ p values with the τ statistics from the original data can indicate if covariate
imbalances still exist.
Section 4.2 details these checks through real data analysis. If these checks display covariate
imbalances which deviate from a randomized experiment, one option would be to re-fit the
ordered logistic model, possibly including interaction terms. Noticeable variations in the
distributions of βˆTX or significant τ dependencies within each subclass, for example, would
suggest that the covariates are not properly balanced. If balance on X cannot be obtained,
causal effects should not be calculated.
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3.2 Analysis phase
Under strong ignorability, if the empirical distribution of the covariates is equal in expectation
between those at different exposure levels within each subclass, estimated mean outcomes for
each treatment level can be computed as weighted averages of the within-subclass sample
means, with weights equal to the relative subclass size. Let y¯kt and y¯ks be the observed sample
means in subclass k among those receiving treatments t and s, respectively. To test for a global
difference in subclass-weighted mean outcomes between the exposure levels, Zanutto et al. [20]
use a randomized block ANOVA model of outcome on subclass and exposure, treating subclass
as the blocking variable. If the global difference in means hypothesis is rejected, pairwise
PATEt,s’s can be estimated using subclass weighted mean differences, as in Equation (9).
̂PATE(t,s) = K∑
k=1
(y¯ktwk − y¯kswk) (9)
Without regression adjustment, however, subclass weighted means may not eliminate the entire
bias caused from differences in the covariates’ distribution, jeopardizing the accuracy of
treatment effects estimated using Equation (9). The intuition behind this is that while
differences in outcomes are unbiased estimates of causal effects at exact values of the linear
predictor, differences in covariates by exposure level could still exist when different linear
predictors are pooled together. Several authors ([38, 39, 40], to name a few) have noted that
combining regression adjustment with matching for a binary treatment reduces bias relative to
either method alone. An additional benefit of regression adjustment is that even in the case that
the theoretical covariate balance of a completely randomized design is achieved within each
subclass, regression adjustment can improve the precision of the causal estimates [34].
We start the analysis by testing for a global effect of exposure using a randomized block
ANCOVA model of outcome on subclass, exposure, and X, treating subclass as the blocking
variable. If the null hypothesis of no difference in means by exposure is rejected, we calculate
pairwise causal effects.
Let Yik be the observed outcome of subject i in subclass k, and let Yik(t) be the potential
outcome of that subject at exposure level t. Next, letting Xik be the observed covariates of
subject i in subclass k, and I(Ti = t) be an indicator function for individual i receiving
treatment t, we use the following steps to estimate PATE(t,s) for all pairs {t, s}.
Step 1 Assuming Yik(t)|Xik ∼ N(E(Yik|Xik, T ), σ
2), model Yik| {Xik, T} within each subclass
using the following regression model
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E(Yik|Xik, T ) =
Z∑
t=1
αktIt(Ti = t) + γkXik (10)
= αk1I(Ti = 1) + ...+ αkZI(Ti = Z) + γkXik
Step 2 Estimate PATEk(t,s), the PATE(t,s) within subclass k, using αˆkt and αˆks, the
maximum likelihood estimates of αkt and αks, respectively, from Model (10):
̂PATEk(t,s) = αˆkt − αˆks (11)
Step 3 Estimate the variance of ̂PATEk(t,s), V ar( ̂PATEk(t,s)), within each subclass, from
regression model (10)
Let αˆ′k = (αˆk1, ..., αˆkZ) with V ar(αˆk) = Σ̂k. Based on (10), αˆk ∼ N (αk,Σk), and letting
c = (0, I(T = t),0,−I(T = s),0), where I(T = t) and I(T = s) are indicators for treatments t
and s, respectively, with 0 = (0, ..., 0), we have
V ar( ̂PATEk(t,s)) = V ar(αˆkt − αˆks) = V ar(cαˆk) = cΣ̂kc′ (12)
Step 4 Using wk =
nk
n
, estimate PATEt,s by averaging over K:
̂PATE(t,s) = K∑
k=1
wk( ̂PATEk(t,s)) (13)
ŜE( ̂PATE(t,s)) =
√√√√ K∑
k=1
w2k(V̂ ar(
̂PATEk(t,s))) (14)
Using our framework, αˆkt − αˆks, the estimated average treatment effect between level t and s in
subclass k, is an unbiased estimate for PATEk(t,s) (For proof, see Appendix A). It is important
to note that because nk and the linear predictors are both based on the GPS model estimated
from the data, responses within and between subclasses are dependent [41]. As a result, the
above aggregation of subclass weighted standard errors can underestimate the true sampling
variances, although regression adjustment usually helps in this regard [41, 42].
3.3 Alternative Approaches
In addition to subclassification based methods, other inference procedures exist for estimating
causal effects from an ordinal exposure. Lu et al. [31] used non-bipartite matching to pair
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subjects at lower exposure levels with ones at higher levels. However, the causal effect estimand
generated using non-bipartite matching is not clearly defined, and a significant effect using this
method would not specify an optimal exposure level.
The approach used by Drichoutis et al. [5], initially described by Lechner [43], is also common
for estimating treatment effects from multiple exposures. Letting nt be the number of subjects
receiving treatment t, this method implements a set of binary comparisons (SBC) attempting to
estimate the population average treatment effect on the treated, PATTt|(t,s) =
E[Y (t)− Y (s)|T = t], for all exposure pairs {t, s}, using propensity score matching for binary
treatment on the population of subjects receiving either t or s. Because SBC yields causal
effects conditional on a subject receiving one of two treatments, the resulting set of causal effects
are usually not transitive. Specifically, the population receiving t which PATTt|(t,s) generalizes
to likely differs from the population receiving s which PATTs|(s,r) generalizes to, and, as a
result, it would be erroneous to use PATTt|(t,s) and PATTs|(s,r) to contrast treatments r and t.
Another approach for approximating the PATE between each exposure pair uses the inverse of
the estimated probabilities from a statistical model of treatment assignment (e.g. multinomial
logistic, proportional odds) as weights [26, 44]. Feng et al. [45] used this procedure to estimate
PATEt,s by weighting subjects by the reciprocal of their GPS.
̂PATEt,s = ̂E[Y (t)]− ̂E[Y (s)] where (15)
̂E[Y (t)] = ( n∑
i=1
I(Ti = t)Yi
r(t,Xi)
)(
n∑
i=1
I(Ti = t)
r(t,Xi)
)−1
and
̂E[Y (s)] = ( n∑
i=1
I(Ti = s)Yi
r(s,Xi)
)(
n∑
i=1
I(Ti = s)
r(s,Xi)
)−1
One issue with this approach is that extreme weights can result in erratic causal estimates
[46, 47], an issue which becomes more likely as the number of treatments increases and
treatment assignment probabilities decrease. While trimming has been shown to decrease the
influence of extreme weights on causal estimates [48], trimming the extreme weights estimated
from a GPS model can yield covariate bias’ in unknown directions [49].
Nonetheless, our subclassification estimators can be viewed as weighted estimators, with weights
coarsened by averaging them through subclasses. For binary treatment, this smoothing of the
weights results in estimates which, compared to weighted methods, are more precise and less
likely to be influenced by a misspecification of the propensity score model [34, 50].
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4 Nutritional label use and BMI
4.1 Data description
The NHANES is a nationally representative research program of 15 United States counties that
measures demographic, health, nutritional, and behavioral variables, including nutritional label
use and BMI. The 2005-06 NHANES version measured label use via a questionnaire and BMI
through a physical examination. Subjects were presented with an example of a food label and
asked the question
‘How often do you use the Nutrition Facts panel when deciding to buy a food product? Would
you say always, most of the time, sometimes, rarely, or never?’ 1
In a separate physical examination, trained medical personnel measured the height and weight
of these subjects.
Thirty pre-treatment covariates that are possibly associated with label use exposure and BMI,
including demographic, lifestyle, nutritional awareness, and health status information, were
chosen after careful examination of the NHANES survey and a vast literature review ([14, 51],
to name a few). All of the variables recommended by Drichoutis et al. [5] were included. We
added squared terms for Metabolic equivalence and Meals away from home to account for the
skewed nature of the original variables [30]. The covariate Weight thoughts, which measures an
individual’s categorized opinion of their weight (underweight, about the right weight, or
overweight), was also included. Lastly, we included the variable Prior BMI, which is calculated
using a self reported estimate of a subject’s weight from a year prior to the survey and the
subject’s current measured height.
The data set included a total of 4,644 subjects with recorded label use and a measured BMI. As
in Drichoutis et al. [5], we excluded the 298 subjects with missing covariates values. Including
Prior BMI as a covariate eliminated an additional 74 subjects, yielding a sample size of 4,272.
Because dealing with missing covariates is not the focus of this paper, we made the naive
assumption that data for these subjects were missing completely at random [52]. Other options
include introducing missing indicators for categorical covariates [53], using weighting methods
based on the probability for missingness (as in [54]), or using multiple imputations to create
complete data sets, where causal effect estimates are calculated across each of the data sets and
combined using Rubin’s rules for multiple imputation [55]. Because these techniques have not
yet been used with GPS methods under multiple exposure levels, it is an important area for
further research. Selected demographic variables of subjects dropped using this criteria and
those remaining in the study population are shown in Appendix C.1.
1See http://www.cdc.gov/nchs/data/nhanes/nhanes 05 06/sp dbq d.pdf for more information
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***************************Table 1 here***************************
Table 1 lists our covariates, their τ statistics with label use, and a p-value testing the null
hypothesis of no dependency between label use and each covariate.2 Using these covariates, the
ordered logistic model was used to estimate the probability of label use (the treatment).
4.2 Balance assessment
Subjects were partitioned into K equal size subclasses, with subclass boundaries defined by
equally spaced quantiles of βˆTX. There were 33 covariates in the propensity score model. To
meet the restrictions of (i) at least 3 + Z subjects at each label use level within each subclass
and (ii) nk>p+ Z, up to K = 15 subclasses were examined. Balance checks are presented for K
= 5, 10, and 15.
4.2.1 Distributions of βˆTX and balance checks for continuous covariates
Boxplots of βˆTX by label use within each subclass show that while the linear predictors are
distributed similarly among those at different label use levels for K = 10 and K = 15, those
with higher label use levels have higher βˆTX within each subclass for K = 5. For example, in
subclass 4 with K = 5, the boxplots indicate a pattern of increasing βˆTX by label use level
(Figure 1). However, when these subjects are further split on βˆTX, as in subclasses 7 and 8 with
K = 10, the linear predictor appears more evenly distributed across label use levels (Figure 1).
***************************Figure 1 here***************************
Boxplots of βˆTX (the linear predictor) by label use in subclass 4 (K=5) and subclasses 7 and 8 (K=10)
Overlap and similarities in the distributions of continuous covariates by label use were also
compared via side by side boxplots, both overall and within each subclass. Extreme continuous
covariates’ values may have large influence on the causal estimates, particularly if the overlap of
continuous variables is not roughly equal across label use levels. One option is to perform the
analysis on a common support of continuous variables, by eliminating subjects whose covariates
are beyond the range of those at other label use levels. For example, sample cutoff lines used
with this inclusion criteria for the variable Prior BMI are shown in Figure 2, which eliminated,
2There are 33 rows in Table 1, as we separated the variable for race into four categories. For a more complete
description of these covariates, see Appendix C.3)
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along other subjects, a subject with a Prior BMI of 87.5. This elimination was done before the
propensity score model was estimated, and would be done prior to any elimination of extreme
linear predictors. Another option was to exclude subjects with extreme continuous variables
within each subclass, but in the NHANES data set, this would eliminate more than 30% of the
participants, and thus this strategy was not attempted. Elimination changes the population for
whom the results can be generalized to, but it reduces the need for extrapolation and making
assumptions which cannot be defended.
***************************Figure 2 here***************************
Boxplots of Prior BMI by label use, with cutoffs for ‘extreme’ values
4.2.2 Within-subclass associations between X and T using Kendall’s τ
As an example of balance assessment using τ , let Drug user be a binary variable for whether or
not a subject indicated using hashish, marijuana, cocaine, heroin, or methamphetamine in the
past 12 months. One significant sample τ statistic occurred with Drug user in subclass 2, for K
= 10 (Table 2). In this example, τ = 0.09, suggesting an increase in label use is associated with
an increase in the likelihood of using drugs, as the z-statistic for this association is 2.00.
***************************Table 2 here***************************
With several hundred such tests, however, we expected to find these associations by chance, as
well. Figure 4 in Appendix B depicts the distributions of the test statistics plotted against a
normal curve, and Table 3 shows the proportion of significant tests observed after
subclassification at level α, α ∈ {0.01, 0.05}. In Figure 4, we look for normality in the
histograms, and in Table 3, because the distribution of p-values is uniform under the null, we
check that the proportion of significant tests is near α. Results are presented across three
choices of K for the following three mechanisms of subject elimination, E1-E3:
E1: No subject elimination, n = 4272
E2: Eliminate subjects with extreme linear predictors, n = 4142
E3: Eliminate subjects with extreme continuous X or extreme linear predictors, n = 4076
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***************************Table 3 here***************************
These checks show that while there were significant within-subclass covariate imbalances beyond
that which would have occurred in a randomized design when K = 5, the proportion of
significant tests of dependency dropped for K = 10 and K = 15. The variables Age, Drug user,
Healthy diet, Heard of food guide pyramid, Pregnant, Prior BMI, Weight thoughts, and Doct.
advice 3: eat less fat for disease risk displayed the strongest (p-value <0.05) tests of
within-subclass dependency for K = 10 and 15.
Lastly, we compare τ statistics before any subclassification with subclass-weighted τ p statistics,
for K = 5 and 15, under elimination mechanism E3 (Figure 3). This figure is an extension of the
‘Love’ plot proposed for binary treatment, which is popular for showing post-matching decrease
in each covariates’ bias [56]. Twenty six of the 33 |τ | statistics using the original data are
greater than 0.02, and 19 of these correlations are greater than 0.10. For K = 15, no |τ | is of
magnitude greater than 0.016, and 29 of the 33 |τ | are less than 0.01. Dependencies appear to
still exist within subclasses for K = 5, where 10 |τ | are greater than 0.02. For K = 10 (not
shown), the largest |τ | is 0.019 (Metabolic Equivalence).
***************************Figure 3 here***************************
Kendall’s τ between covariates and label use, before and after stratification (using K = {5, 15})
These results suggest that subclassifying with K= 10 and 15 eliminated most of the differences
in observed covariate distributions across label use categories which were found in the original
data. Because our checks deem covariates to be plausibly balanced for these K’s only, we do not
estimate within-subclass causal effects for K = 5.
4.3 Subclass weighted causal effect estimates of label use on BMI with
regression adjustment
Let BMIik(t) be the potential outcome BMI of subject i in subclass k at label use t, for
i = 1, ..., n, k = 1, ...,K, K ∈ {10, 15}, and
t ∈ {1 = never, 2 = rare, 3 = some, 4 = most of the time (often), 5 = always} . With Z = 5 and
Yik(t) = BMIik(t), Equations 10-14 were used to estimate the PATE(t,s) and their variances for
all pairs {t, s}.
Estimates for three forms of subject elimination (E1-E3) and two regression model adjustments
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(A1-A2) are shown in Table 4. The regression adjustment models were used to adjust for
lingering bias that was not eliminated using subclassification. Model A1 included the set of
covariates with questionable balance as judged by within subclass τ statistics, as described in
Section 4.2, and model A2 included all covariates in Table 1.
A1: X = Age, Drug user, Healthy diet, Heard of food guide pyramid,Pregnant, Prior BMI,
Weight thoughts, and Doct. advice 3: eat less fat for disease risk (See Appendix C.3 for
variable definitions)
A2: X = All covariates in Table 1
Two other sets of causal effects are presented in Table 4. First, estimates calculated using SBC,
as detailed in Section 3.3 and calculated by Drichoutis et al. [5] with this same data set, are
displayed.3 Second, we calculated IPTW estimates of the PATE’s, as in Feng et al. [45] and
Equation 15.4
***************************Table 4 here***************************
5 Results
Using a randomized block ANCOVA model with K = 10 and K = 15 subclasses as blocks, at
the 0.05 nominal level, we rejected the global null hypothesis of no differences between the mean
BMI’s at each label use (p <0.01 for both K, using each combination of unit discarding rule
(E1-E3) and regression adjustment method (A1,A2)). Examining the estimated PATE’s
between the 10 pairs of label levels suggest that often or always label use may yield lower BMI
than rare or sometimes usage. However, the majority of comparisons are not significant at the
0.05 level; the one comparison that was significant across most models examined suggests that
an often usage yields a lower BMI than a rare one. Effect estimates are similar for different
unit discarding rules (E1-E3), choice of K, and regression adjustment method (A1,A2). IPTW
estimates are mostly inconclusive, save for limited evidence that often levels cause lower BMI
than rare and sometimes levels.
The marginal increase in BMI with low levels of label use, relative to no label use, is a bit of a
3[5] used several matching algorithms in their analysis. The estimates shown in Table 4 reflect those using
one-to-one nearest-neighbor matching.
4As in [45], we used bootstrap sampling to estimate the variance of the IPTW causal effects.
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surprise; one possibility is that subjects who read labels at a minimum level falsely believe that
they are acting sufficiently healthy, and respond with behaviors or eating habits which increase
BMI. Another possibility is that the strong ignobility assumption is violated, which implies that
subjects reading at the rare levels are unique in a dimension not captured by the observed
covariates. However, this violation is less plausible when a large number of covariates are being
balanced.
The causal estimates provided are only unbiased under the assumptions specified in Section 2.
SUTVA seems reasonable for the NHANES. However, we caution that merging label use
categories into two levels (as in [3, 4]) may violate the multiple version of treatment assignment
assumption. The NHANES data also included other covariates that were not included in the
GPS model because we felt that other variables served as sufficient proxies. As a sensitivity
analysis, we examined six of these covariates: cocaine use, marijuana use, marital status, an
indicator for excessive alcohol consumption, blood pressure problems, and desires for weight
control (listed in Appendix C.2, along with their pre-subclassification Kendall’s τ with label
use). Using our split of subjects into 15 subclasses, we tested for within-subclass dependency
between label use and these covariates using Kendall’s τ . Of the 90 tests, 1 (1.1%) and 4 (4.4%)
were significant at α = 0.01 and α = 0.05, respectively, roughly what would have occurred in a
randomized design. Thus, it appears that we were able to balance observed covariates even
when they were not explicitly included in the GPS model.
Our decision to eliminate subjects with extreme linear predictors or continuous variables (E2,
E3) results in estimands that are different than PATE’s, and the estimates provided in Table 4
each generalize to different populations. However, under both E2 and E3, fewer than 5% of
subjects were eliminated. Two variables, education level and familiarity with the food guide
pyramid, offered the strongest insight into why subjects were not retained. Of the 130 subjects
eliminated under E2 and the 196 subjects dropped under E3, 61 had the lowest education level
and had no knowledge of the food guide pyramid. An additional 46 eliminated subjects had the
highest education level and were familiar with the food guide pyramid. These types of subjects
were less likely to be observed at all label use levels and would require extrapolation.
Compared to other methods for ordinal exposures applied to this data set, subclassification with
regression adjustment provides important advantages. In the IPTW analysis, 309, 313, and 307
subjects were given a weight greater than 10 under E1, E2, and E3, respectively, yielding causal
effects with larger variances in comparison to our proposed method. The maximum weights
under the three elimination mechanisms were 129 (E1), 108 (E2), and 57 (E3). Subclassification
based estimates are also transitive and generalizable to the entire study population that is not
discarded, whereas estimates using a SBC generalize to separate subsets of the population and
are not transitive. Here, transitivity refers to the additive effects of causal estimates across
different exposure levels. For example, using our method, but not that of a SBC, the additive
effects of often to some and some to rare label use frequency is equivalent to comparing often
to rare usage.
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6 Simulation
In real data, true causal effects are not known because each subject receives only one treatment
or exposure dose at a specific time point. If complete sets of potential outcomes were known for
all subjects, however, it would be straightforward to compare competing methods to see which
most accurately and precisely estimates the true PATE. Thus, we created two full data sets
that include the full set of potential outcomes which could have occurred if we had observed the
subjects at all label use levels. The two sets of full data, Set 1 and Set 2, used the 2005-06
NHANES with label use as exposure and BMI as outcome. Letting BMIi(t) be the potential
outcome BMI under treatment t for subject i, we imputed two fixed sets of potential outcomes
as follows:
SET 1 PATE(t,s) = 0 for all {t, s}. Here, BMIi(t) = BMIi for all t ∈ T , where BMIi is the
observed BMI for unit i in the data set.
SET 2 PATE(t,s) 6= 0 for all pairs {t, s}. Imputation of these potential outcomes were obtained
using the following algorithm.
1. The principal components of X, the matrix of covariates listed in Table 1, were
calculated.5
2. All subjects were projected to the eigenvector (V1) that corresponded to the largest
eigenvalues of X, PC1i = V
T
1
Xi.
3. BMIi(Ti), the potential outcome at subject i’s observed treatment assignment, was
set as the observed outcome, BMIi.
4. For t 6= Ti, the potential outcomes were imputed using the observed BMI outcomes of
the subjects receiving other treatment levels whose PC1’s were closest to that of
subject i. Specifically, BMIi(t) = BMIj(t) = BMIj,∀ t = Tj = Tj′ 6= Ti, where
|PC1i − PC1j| ≤ |PC1i − PC1j′ | ∀ j
′.
For Set 2, the resulting population average causal effects for the different usage level
comparisons were: -0.14 (rare vs. never), -0.18 (some vs. never), -1.20 (often vs. never), and
0.32 (always vs. never).
At each simulation step, we applied the following algorithm:
5Here, we excluded the squared terms for Metabolic equivalenceand Meals away from home, as the inclusion of
these variables led to erratic principal components. For more information on the principal components procedure,
see [57].
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1. Randomly select 15 of the covariates listed in table 1 without replacement, and let Xsim
be the matrix with these covariates
2. Estimate γˆt, the maximum likelihood estimate of γ from the multinomial logisitic
regression model log( P (T=t)
P (T=z)) = γtXsim based on the observed T and Xsim.
3. Let rˆsim,i(t,Xsim) be the estimated probability that unit i received treatment t, based on
the model in the previous step with γ= γˆ, and sample Tsim,i based on
rˆsim,i = (rˆ(1,Xsim,i), . . . , rˆ(5,Xsim,i)).
4. Set the observed outcome BMIsim,i = BMI(Tsim,i).
It is important to note that both the treatment assignment mechanism and the outcome model
are different than the GPS model and the linear regression model, respectively. We used
BMIsim, Tsim, and Xsim to compare seven methods of estimating the PATE across pairs of
label use dosages. The seven methods included four variations of subclassification and three
commonly used comparison approaches. Subclassification techniques were generated by
combining two factors, the number of subclasses used (K = 5, 15) and whether or not regression
adjustment for all covariates in X was used within each subclass (yes, no). The three commonly
used estimation methods included the naive differences in the sample means of BMIsim between
those at different treatment levels, ̂PATEt,s = 1nt (∑ni=1BMI(sim,i) ∗ I(Tsim = t)) -
1
ns
(
∑n
i=1BMI(sim,i) ∗ I(Tsim = s)). The second method used standard regression adjustment of
BMIsim on Tsim and X, with the causal effects estimated using the coefficients on Tsim. The
last method relied on IPTW with normalized weights (Equation (15)). In this calculation,
subjects receiving level t were weighted by 1/(Pr(Tsim = t)), where Pr(Tsim = t) was calculated
using the proportional odds model.
At each simulation m, m = 1, ..., 2000, we estimated ̂PATEm(t,s) and its standard error,
SE( ̂PATEm(t,s)), for each of the seven estimating procedures and dose comparisons. This
yielded simulated bias (biasm) and coverage indicators (coveragem, allcoveragem) for each
procedure at each m:
biasm(t,s) = ̂PATEm(t,s) − PATE(t,s)
coveragem(t,s) =
{
1 if PATEt,s ∈ ̂PATEm(t,s) ± 1.96 ∗ SE( ̂PATEm(t,s)), 0 otherwise}
allcoveragem =
{
1 if coveragem(t,s) = 1 for all pairs {t, s} , t 6= s, 0 otherwise
}
The mean bias, biast,s =
1
2000
∑2000
m=1 biasm(t,s), was calculated for each of the ten pairs of dose
comparisons, as well as the standard deviation of bias. We present results for the four dose
comparisons with never label use, as results for other mean bias calculations are similar. Two
summary statistics for coverage rates, Average and Complete coverage, are also shown for each
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method, where
Average =
1
20000
2000∑
m=1
10∑
t,s
coveragem(t,s)
Complete =
1
2000
2000∑
m=1
allcoveragem(t,s)
Because we did not adjust for multiple interval estimations, Complete coverage is expected to
be lower than both Average coverage and the nominal level.
***************************Table 5 here***************************
Results of the simulations are depicted in Table 5. Regression alone and subclassification with
regression adjustment yielded the lowest bias for Set 1, PATEt,s = 0. All of the subclassification
approaches showed lower bias and higher coverage rates for Set 2, PATEt,s 6= 0, compared to
the other methods. Among the subclassification methods implemented, a higher number of
subclasses and the inclusion of regression adjustment tended to yield higher coverage rates and
lower bias. IPTW estimates showed higher bias and lower coverage, possibly due to the
misspecified treatment assignment model or the sensitivity of this procedure to large weights.
With a binary treatment assignment, misspecified treatment assignment models and extreme
weights can yield causal effects with larger bias and higher MSE [47, 50, 58].
The results of our simulations suggest that when the estimated treatment assignment
mechanism, in this case the proportional odds model, does not reflect the true assignment
mechanism, a method involving subclassification with regression adjustment can outperform
competing estimators of PATE for ordinal exposures. Further, combining subclassification with
regression adjustment yields lower bias and higher coverage rates when compared to either
method alone.
7 Discussion
The analysis presented here adds to that of Variyam and Cawley [3] and Loureiro et al. [4], who
dichotomized label use as sometimes or higher and found significant health benefits of increased
label use. We showed that a significant benefit of reading nutritional labels comes only with an
often or always frequency, relative to reading at a rare frequency. Such a conclusion could not
be reached after dichotomizing the exposure or by other previously proposed methods. In fact,
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we estimated the treatment effect in our data set after dichotomizing label use into sometimes
or higher and rare or never levels. Under E1 elimination mechanism, and using subclassification
on the propensity score with K = 15 subclasses followed by regression adjustment, the
estimated effect was not significant at the 0.05 nominal level (-0.05, 95% CI, -0.29, 0.19).
Although the direction of this effect was similar to our findings, this analysis did not capture the
potential benefits of reading labels frequently. We recommend that policies and instructions for
label use be updated to specify the extent with which one needs to read labels to reap the health
benefits of a lower BMI.
Subclassification on a GPS requires two assumptions, SUTVA and strong unconfoundedness. In
our study, both assumptions seem reasonable given the design of the NHANES and the large
number of observed covariates which were sufficiently balanced within each subclass, however
the true validity of both of assumptions is unknown. Sensitivity approaches have been developed
for binary treatment effects (see [59, 60, 61, 62], to name a few), and a useful area for further
research would examine the validity of these assumptions with an ordinal treatment. Further,
because the NHANES is not a random sample, but a stratified random sample, our treatment
effects generalize specifically to the population created by the sample; see [63] and [64] for
related discussions on the generalizability of observational data.
Inference using propensity scores is a preferred method of answering causal questions for
comparative effectiveness research (CER), but generalizations of propensity scores to the
multiple treatment setting are limited [65, 66]. The balance and estimation procedures provided
here are important extensions of propensity score analysis to causal effects estimation for
observational studies when the exposure is ordinal. These procedures yield, under proper
assumptions, unbiased and transitive estimates of average treatment effects.
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Table 1: Covariates & Kendall’s τ with nutritional label use
Variable Type Kendall’s τ p-value
Gender, male Binary −0.19 <0.001
Race, Hispanic Binary −0.14 <0.001
Household size Numeric −0.13 <0.001
Born to be fat? Ordinal −0.07 <0.001
Drug user Binary −0.05 <0.001
Smoker Binary −0.04 0.003
Safe sex Binary −0.01 0.338
Race, black Binary 0.00 0.867
Heart disease Binary 0.00 0.816
Drinks per day Numeric 0.00 0.699
Race, other Binary 0.01 0.292
Pregnant Binary 0.01 0.430
(Meals away from home)2 Numeric 0.02 0.060
Meals away from home Numeric 0.02 0.048
Prior BMI Numeric 0.04 0.001
Age Numeric 0.06 <0.001
Diabetic medicine Binary 0.07 <0.001
Diabetic Binary 0.10 <0.001
Race, white Binary 0.11 <0.001
Doct. advice 2 (reduce weight for chol.) Binary 0.11 <0.001
Doct. advice 3 (less fat for disease risk) Binary 0.11 <0.001
Income Ordinal 0.12 <0.001
Weight thoughts Ordinal 0.12 <0.001
Food security Ordinal 0.13 <0.001
Doct. advice 1 (less fat for chol.) Binary 0.13 <0.001
Doct. advice 4 (reduce weight for disease risk) Binary 0.13 <0.001
Healthy diet Binary 0.16 <0.001
(Metabolic Equivalence)2 Numeric 0.16 <0.001
Metabolic equivalence Numeric 0.18 <0.001
Heard of diet guidelines Binary 0.24 <0.001
Heard of 5-a-day program Binary 0.24 <0.001
Education Ordinal 0.25 <0.001
Heard of food pyramid Binary 0.28 <0.001
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Table 2: Label Use by Drug User, subclass 2, K = 10
Drug user Never Rare Some Often Always
Yes 11 7 15 7 7
No 148 48 85 54 36
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Table 3: Proportion of significant (p-value < α) within-subclass balance tests
Elimination K (# subclasses) α = 0.01 α = 0.05
E1
5 0.018 0.103
10 0 0.052
15 0.004 0.042
E2
5 0.012 0.115
10 0.009 0.079
15 0.006 0.053
E3
5 0.018 0.097
10 0.006 0.064
15 0.014 0.048
29
Table 4: PATE estimates (standard errors in parenthesis) of BMI due to increased nutritional label use
Elim. K Adjust. Rare v
Never
Some v
Never
Often v
Never
Always v
Never
Some v
Rare
Often v
Rare
Always v
Rare
Often v
Some
Always v
Some
Always v
Often
E1
10
A1 0.30
(0.18)
0.13
(0.14)
−0.09
(0.16)
−0.09
(0.17)
−0.17
(0.17)
−0.39
(0.19)**
−0.39
(0.20)
−0.22
(0.16)
−0.22
(0.16)
0.00
(0.18)
A2 0.26
(0.18)
0.19
(0.15)
−0.07
(0.17)
−0.08
(0.17)
−0.07
(0.18)
−0.33
(0.20)
−0.35
(0.20)
−0.26
(0.16)
−0.27
(0.17)
−0.01
(0.19)
15
A1 0.29
(0.18)
0.17
(0.14)
−0.08
(0.17)
0.01
(0.17)
−0.12
(0.17)
−0.36
(0.19)
−0.28
(0.20)
−0.24
(0.16)
−0.16
(0.17)
0.08
(0.19)
A2 0.25
(0.19)
0.17
(0.15)
−0.09
(0.17)
−0.03
(0.18)
−0.07
(0.18)
−0.34
(0.20)
−0.27
(0.21)
−0.26
(0.17)
−0.20
(0.17)
0.06
(0.19)
E2
10
A1 0.33
(0.18)
0.14
(0.14)
−0.10
(0.16)
−0.08
(0.17)
−0.20
(0.17)
−0.43
(0.19)**
−0.41
(0.19)**
−0.23
(0.15)
−0.21
(0.16)
0.02
(0.18)
A2 0.30
(0.18)
0.17
(0.15)
−0.10
(0.17)
−0.10
(0.17)
−0.13
(0.17)
−0.40
(0.19)**
−0.39
(0.20)
−0.27
(0.16)
−0.26
(0.17)
0.00
(0.18)
15
A1 0.32
(0.18)
0.12
(0.14)
−0.08
(0.17)
−0.05
(0.17)
−0.20
(0.17)
−0.41
(0.19)**
−0.37
(0.20)
−0.20
(0.16)
−0.17
(0.17)
0.04
(0.19)
A2 0.28
(0.19)
0.14
(0.15)
−0.09
(0.17)
−0.08
(0.18)
−0.14
(0.18)
−0.37
(0.20)
−0.36
(0.21)
−0.22
(0.16)
−0.22
(0.17)
0.01
(0.19)
E3
10
A1 0.39
(0.17)**
0.15
(0.14)
−0.08
(0.16)
0.00
(0.16)
−0.24
(0.16)
−0.47
(0.18)**
−0.40
(0.19)**
−0.23
(0.15)
−0.15
(0.16)
0.08
(0.17)
A2 0.36
(0.18)**
0.19
(0.14)
−0.04
(0.16)
−0.02
(0.17)
−0.17
(0.17)
−0.40
(0.18)**
−0.38
(0.19)**
−0.23
(0.15)
−0.22
(0.16)
0.01
(0.17)
15
A1 0.33
(0.18)
0.15
(0.14)
−0.08
(0.16)
0.01
(0.17)
−0.18
(0.17)
−0.40
(0.18)**
−0.32
(0.19)
−0.22
(0.15)
−0.14
(0.16)
0.09
(0.17)
A2 0.25
(0.18)
0.21
(0.14)
−0.10
(0.16)
−0.03
(0.17)
−0.04
(0.17)
−0.35
(0.19)
−0.28
(0.20)
−0.31
(0.15)**
−0.24
(0.16)
0.06
(0.18)
SBC (as in [5]) -0.04
(0.69)
0.95
(0.43)**
0.60
(0.54)
0.13
(0.65)
-0.45
(0.55)
0.79
(0.67)
0.54
(0.69)
0.34
(0.41)
-0.63
(0.51)
-0.07
(0.48)
IPTW (as in [45], E1) 0.49
(0.42)
0.39
(0.31)
-0.10
(0.35)
0.53
(0.42)
-0.08
(0.41)
-0.58
(0.42)
0.05
(0.47)
-0.50
(0.29)
0.14
(0.45)
0.63
(0.43)
IPTW (as in [45], E2) 0.52
(0.46)
0.29
(0.31)
-0.24
(0.36)
0.53
(0.43)
-0.23
(0.46)
-0.76
(0.43)
0.01
(0.49)
-0.53
(0.34)
0.24
(0.44)
0.77
(0.41)
IPTW (as in [45], E3) 0.59
(0.41)
0.61
(0.31)
-0.01
(0.31)
0.54
(0.38)
0.02
(0.46)
-0.61
(0.36)
-0.06
(0.42)
-0.62
(0.29)**
-0.08
(0.40)
0.55
(0.38)
E1: No subject elimination
E2: Eliminate subjects with extreme linear predictors
E3: Eliminate subjects with extreme continuous X or extreme linear predictors
A1: X = selected covariates (See Section 4.2)
A2: X = all covariates
**Significant at 0.05 level
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Table 5: Simulated coverage, bias, and standard deviation of bias of seven PATE estimators using two hypothetical full data sets
Coverage % Mean bias (SD) by label use comparison, vs. Never
PATE Estimator Average* Complete** Rare Some Often Always
Set 1 PATEt,s = 0
Subclass only, K=5 0.91 0.60 0.18 (0.41) 0.12 (0.34) −0.07 (0.35) 0.14 (0.34)
Subclass w/ Regression, K=5 0.91 0.72 0.01 (0.17) −0.01 (0.13) 0.01 (0.13) −0.01 (0.15)
Subclass only, K=15 0.95 0.59 0.15 (0.43) 0.08 (0.35) −0.12 (0.35) 0.08 (0.34)
Subclass w/ Regression, K=15 0.96 0.74 0.00 (0.17) −0.00 (0.14) 0.00 (0.14) 0.02 (0.16)
Naive difference in means 0.77 0.22 0.45 (0.40) 0.50 (0.38) 0.44 (0.45) 0.66 (0.48)
Standard regression 0.94 0.70 0.01 (0.16) 0.00 (0.14) 0.00 (0.14) −0.00 (0.14)
IPTW 0.88 0.57 0.67 (0.36) 0.46 (0.41) 0.06 (0.49) 0.58 (0.62)
Set 2 PATEt,s 6= 0
Subclass only, K=5 0.97 0.80 0.08 (0.39) 0.05 (0.28) 0.06 (0.31) 0.06 (0.35)
Subclass w/ Regression, K=5 0.96 0.80 0.03 (0.38) −0.02 (0.27) 0.03 (0.31) 0.03 (0.34)
Subclass only, K=15 0.96 0.80 0.06 (0.41) 0.02 (0.30) 0.00 (0.32) 0.04 (0.37)
Subclass w/ Regression, K=15 0.97 0.78 0.03 (0.43) −0.01 (0.30) 0.02 (0.34) 0.04 (0.37)
Naive difference in means 0.83 0.26 0.29 (0.36) 0.41 (0.28) 0.73 (0.31) 0.24 (0.34)
Standard regression 0.90 0.52 −0.01 (0.36) 0.05 (0.25) 0.21 (0.27) −0.31 (0.31)
IPTW 0.76 0.30 0.64 (0.37) 0.81 (0.33) 1.93 (0.36) 1.03 (0.40)
* Fraction of all ̂PATE intervals containing the true PATE
** Fraction of simulations with all 10 pairwise ̂PATE intervals containing the true PATE
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A Proof of unbiasedness
Here we show that ̂PATEk(t,s) is unbiased for PATEk(t,s). With Yik(t)|Xik ∼ N(µikt, σ2) as in
Equation 10, we model Yik| {Xik, T} within each subclass, where
µikt =
Z∑
t=1
αktIt(Ti = t) + γkXik
= αk1I(Ti = 1) + ..αkZI(Ti = Z) + γkXik
and ̂PATEk(t,s) = αˆkt − αˆks
Using αˆkt and αˆks, the maximum likelihood estimates of αkt and αks, we have
E[αˆkt − αˆks] = E[αkt − αks] [67].
Next we show E[αkt − αks] = PATEk(t,s). As in Section 3.1, we assume the covariate
distribution within each subclass is equal in expectation between those at different doses, that
E[Xik|T = t] = E[Xik|T = s] (App. 1)
By properties of the Normal distribution, E[Yik|Xik, T = t] = αkt + γkXik and
E[Yik|Xik, T = s] = αks + γkXik, thus:
E[αkt − αks] = E[αkt]− E[αks]
= E[E[Yik(t)|Xik, T = t]]− E[[Yik(s)|Xik, T = s]] (by App. 1)
= E[E[Yik(t)|Xik]]− E[[Yik(s)|Xik]] (by unconfoundedness)
= E[Yik(t)]− E[Yik(s)]
= PATEk(t,s)
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B Figures
***************************Figure 4 here***************************
Histograms of z-test statistics of statistical dependency between covariates and label use using Kendall’s τ , for K
subclasses and subject elimination E1-E3
E1: No subject elimination, n = 4272
E2: Eliminate subjects with extreme linear predictors, n = 4142
E3: Eliminate subjects with extreme continuous X or extreme linear predictors, n = 4076
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C Tables
C.1 Study population & those excluded
This table gives study characteristics of subjects included and excluded from our study for
having missing covariate values (% shown unless otherwise indicated)
Covariate Description
In study Eliminated
n = 4272 n = 372
Age mean (SE) 47.3 (18.5) 53.2 (20.8)
BMI mean (SE) 28.8 (6.8) 28.7 (6.4)
Metabolic equivalence mean (SE) 8.6 (12.1) 7.9 (4.5)
Diabetic 74 74
Drug user 8 5
Heard of diet guidelines 43 29
Gender Males 48 48
Nutritional label use
Never 32 45
Rare 10 10
Some 22 20
Most of the time 19 12
Always 17 14
Race
Hispanic 22 39
white 51 39
black 23 19
other 4 3
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C.2 Covariates not included in propensity score model
This table shows variables not included in our propensity score model (which were eventually
balanced on through subclassification), and their original Kendall’s τb correlation with label use
Variable Description Kendall’s τb p-value
Blood pressure problems Binary 0.07 <0.001
Cocaine use Binary −0.01 0.60
Marijuana use Binary −0.05 <0.001
Marital status (Yes vs. No) Binary 0.03 0.03
Ever drink 5+ drinks per day Numeric −0.06 <0.001
Weight control Binary 0.11 <0.001
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C.3 Covariates used & a brief description
Type Variable Name Description/Levels
Numeric
Age Years of respondent
Drinks per day # of alcoholic drinks consumed per day over the past 12 months
Household size # of people in household
Meals away from home # weekly meals prepared outside of home
Metabolic equivalence Total metabolic activity rate
Prior BMI Calculated using respondent’s estimate of their weight from one-year ago and their cur-
rent height
Ordinal
Born to be fat? Are people born to be fat? Respondent answers: strongly disagree, somewhat disagree,
neither agree nor disagree, somewhat agree, or strongly agree
Education HS/GED, some college or associate’s degree, or college graduate
Food security Household food security: low, marginal, or full
Income Household income: Less than $24,999/yr, between $25,000 and $54,999/yr, or greater
than $55,000/yr
Weight thoughts Respondent’s thoughts on his or her own weight: underweight, about the right weight,
or overweight
Nominal
Race Hispanic, non-Hispanic white (white), non-Hispanic black (black), Other
Diabetic Respondent has been told by a doctor of diabetes or pre-diabetic conditions
Diabetic medicine Respondent takes insulin or pills for diabetes
Doct. advice 1 Doctor’s advice to respondent: eat less fat for cholesterol
Doct. advice 2 Doctor’s advice to respondent: reduce weight for cholesterol
Doct. advice 3 Doctor’s advice to respondent: eat less fat for disease risk
Doct. advice 4 Doctor’s advice to respondent: reduce weight for disease risk
Drug user Respondent has used hashish, marijuana, cocaine, heroin, or methamphetamine in the
past month
Gender Male, female
Healthy diet Respondent rates diet as good or better
Heard of 5-a-day program Respondent has heard of 5-a-day program
Heard of diet guidelines Respondent has heard of diet guidelines
Heard of food guide pyramid Respondent has heard of food guide pyramid
Heart disease Respondent suffers from coronary heart disease, stroke, or liver condition
Pregnant Respondent is pregnant
Safe sex Respondent has not had sex without a condom in the past year
Smoker Respondent smokes cigarettes
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